Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
Work
Year: 2012
Type: article
Abstract: Blockade of programmed death 1 (PD-1), an inhibitory receptor expressed by T cells, can overcome immune resistance. We assessed the antitumor activity and safety of BMS-936558, an antibody that specif... more
Source: New England Journal of Medicine
Authors Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer, Scott Gettinger, David C. Smith +25 more
Institutions Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Dana-Farber Cancer Institute, Yale Cancer Center, Yale University +10 more
Cites: 27
Cited by: 11,670
Related to: 10
FWCI: 433.6
Citation percentile (by year/subfield): 100
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze